Article(id=1327671167764247197, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671134016876766, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.12.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1660320000000, receivedDateStr=2022-08-13, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471073331, onlineDateStr=2026-11-12, pubDate=1670601600000, pubDateStr=2022-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471073331, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471073331, creator=13701087609, updateTime=1794471073331, updator=13701087609, issue=Issue{id=1327671134016876766, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='12', pageStart='1671', pageEnd='1823', issueExtLink='null', onlineDate='null', pubDate='1670601600000', pubDateStr='2022-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471065286, creator='13701087609', updateTime=1794472341615, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327676487970435149, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671134016876766, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327676487970435150, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671134016876766, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1671, endPage=1682, ext={EN=ArticleExt(id=1327671169685238433, articleId=1327671167764247197, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Application Status and Research Progress on Safety of Gene Therapy Delivery Vectors, columnId=1327671169563603616, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives, runingTitle=null, highlight=null, articleAbstract=

The efficient delivery of genes to target tissues or target cells by vectors is a critical step in gene therapy. Selecting a suitable, safe, and effective gene delivery vector is an urgent task in gene therapy. Gene therapy delivery vectors can be divided into two categories, viral vectors and nonviral vectors. In this review, the current application status and safety of viral vectors, synthetic nonviral vectors, and biological nonviral vectors are summarized, and the advantages and disadvantages of various delivery vectors are compared. Furthermore, the key points for evaluating the nonclinical safety of gene delivery vectors are summarized to provide references for the selection, application, and safety evaluation of vectors in the field of gene therapy.

, authors=Manqi LI1, Liping WEI1, 2, Qiaoyu TAO2, 3, Weiwei HE1, Yan CHANG1, *, authorsList=Manqi LI, Liping WEI, Qiaoyu TAO, Weiwei HE, Yan CHANG, authorCompany=null, correspAuthors=Yan CHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327671170486350503, articleId=1327671167764247197, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=基因治疗递送载体应用现状及安全性研究进展, columnId=1327671169823650466, journalTitle=中国医药工业杂志, columnName=专论, runingTitle=null, highlight=null, articleAbstract=

通过载体将基因药物高效递送至靶组织或靶细胞是基因治疗的关键步骤。选择合适、安全、有效的递送系统是基因疗法中亟待解决的任务。目前采用的基因药物递送载体可分为病毒载体和非病毒载体。该综述介绍了基因治疗中常见的病毒载体、合成非病毒载体和生物非病毒载体的应用现状和相关安全性问题,比较了不同载体的优缺点,并总结了基因递送载体非临床安全性评价考虑要点,以期为基因治疗领域的载体的选择、使用及安全性评价提供参考。

, authors=李嫚琪1, 魏丽萍1, 2, 陶巧玉2, 3, 何伟伟1, 常艳1, *, authorsList=李嫚琪, 魏丽萍, 陶巧玉, 何伟伟, 常艳, authorCompany=null, correspAuthors=常艳, authorNote=

常艳,女,博士,中国毒理学会认证毒理学家(DCST),荣获“上海市科学技术带头人”“上海领军人才”“上海市三八红旗手”等称号以及“上海市五一劳动奖章”,现任上海益诺思生物技术股份有限公司总经理。中国医药工业研究总院研究员,博士生导师;复旦大学博士生导师;长三角药学高等工程学院硕士生导师;上海工程技术大学硕士生导师。兼任国家食品药品监督管理局药品审评及GLP检查专家、OECD Pig-a指导原则专家组成员、NMPA CDE ICH S5和S12专家组成员、NMPA CDE遗传毒性指导原则专家组成员。长期从事新药安全性评价研究,承担或参与国家级及其他政府科技项目20余项,累计发表文章70余篇,累计申请国内专利14项,其中发明专利3项,已授权专利10项。共培养博士研究生1名(以毕业计),另有7名在读;共培养硕士研究生15人(以毕业计),另有在读6人。

李嫚琪(1997—),女,硕士,从事药物毒理学研究。

, correspAuthorsNote=
常艳(1974—),女,研究员,博士生导师,从事药物毒理学研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=zkop+Zn8H1NsUCs1W+an9A==, magXml=69KtURX/rVdUbEvWUkS0Tw==, pdfUrl=null, pdf=IjSkWgNFGlYtZNvYVsuSkQ==, pdfFileSize=1857197, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=RU33ta1rX0XWjKH/4JY7VQ==, mapNumber=null, fund=null)}, authors=[Author(id=1327671327286211555, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671327365903333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327286211555, language=EN, stringName=Manqi LI, firstName=Manqi, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671327433012198, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327286211555, language=CN, stringName=李嫚琪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203, bio={"content":"

李嫚琪(1997—),女,硕士,从事药物毒理学研究。

"}, bioImg=null, bioContent=

李嫚琪(1997—),女,硕士,从事药物毒理学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671327063913433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=1., ext=[AuthorCompanyExt(id=1327671327072302042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671327080690651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1327671327491732456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671327567229931, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327491732456, language=EN, stringName=Liping WEI, firstName=Liping, middleName=null, lastName=WEI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203
2.InnoStar Biotech Nantong Co., Ltd., Nantong 226133, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671327642727404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327491732456, language=CN, stringName=魏丽萍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203
2.益诺思生物技术南通有限公司,江苏 南通 226133, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671327063913433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=1., ext=[AuthorCompanyExt(id=1327671327072302042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671327080690651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203)]), AuthorCompany(id=1327671327143605212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=2., ext=[AuthorCompanyExt(id=1327671327147799517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327143605212, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.InnoStar Biotech Nantong Co., Ltd., Nantong 226133), AuthorCompanyExt(id=1327671327156188126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327143605212, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.益诺思生物技术南通有限公司,江苏 南通 226133)])]), Author(id=1327671327705641966, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671327793722353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327705641966, language=EN, stringName=Qiaoyu TAO, firstName=Qiaoyu, middleName=null, lastName=TAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2.InnoStar Biotech Nantong Co., Ltd., Nantong 226133
3.College of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671327869219826, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327705641966, language=CN, stringName=陶巧玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2.益诺思生物技术南通有限公司,江苏 南通 226133
3.安徽中医药大学药学院,安徽 合肥 230012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671327143605212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=2., ext=[AuthorCompanyExt(id=1327671327147799517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327143605212, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.InnoStar Biotech Nantong Co., Ltd., Nantong 226133), AuthorCompanyExt(id=1327671327156188126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327143605212, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.益诺思生物技术南通有限公司,江苏 南通 226133)]), AuthorCompany(id=1327671327214908383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=3., ext=[AuthorCompanyExt(id=1327671327223296992, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327214908383, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.College of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230012), AuthorCompanyExt(id=1327671327231685601, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327214908383, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.安徽中医药大学药学院,安徽 合肥 230012)])]), Author(id=1327671327965688820, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671328045380598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327965688820, language=EN, stringName=Weiwei HE, firstName=Weiwei, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671328120878071, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327965688820, language=CN, stringName=何伟伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671327063913433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=1., ext=[AuthorCompanyExt(id=1327671327072302042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671327080690651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1327671328179598329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=ychang@innostar.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327671328250901499, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671328179598329, language=EN, stringName=Yan CHANG, firstName=Yan, middleName=null, lastName=CHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671328305427452, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671328179598329, language=CN, stringName=常艳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671327063913433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=1., ext=[AuthorCompanyExt(id=1327671327072302042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671327080690651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203)])])], keywords=[Keyword(id=1327671328431256573, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=EN, orderNo=1, keyword=gene delivery vector), Keyword(id=1327671328489976830, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=EN, orderNo=2, keyword=viral vector), Keyword(id=1327671328544502783, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=EN, orderNo=3, keyword=nonviral vector), Keyword(id=1327671330218029056, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=EN, orderNo=4, keyword=synthetic vector), Keyword(id=1327671330339663873, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=EN, orderNo=5, keyword=biological vector), Keyword(id=1327671330398384130, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=EN, orderNo=6, keyword=safety), Keyword(id=1327671330465492995, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=CN, orderNo=1, keyword=基因递送载体), Keyword(id=1327671330524213252, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=CN, orderNo=2, keyword=病毒载体), Keyword(id=1327671330582933509, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=CN, orderNo=3, keyword=非病毒载体), Keyword(id=1327671330641653766, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=CN, orderNo=4, keyword=合成载体), Keyword(id=1327671330708762631, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=CN, orderNo=5, keyword=生物载体), Keyword(id=1327671330767482888, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, language=CN, orderNo=6, keyword=安全性)], refs=[Reference(id=1327671331035918346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=ALHAKAMY N A, CURIEL D T, BERKLAND C J.The era of gene therapy: from preclinical development to clinical application [J].Drug Discov Today, 2021, 26(7): 1602-1619., articleTitle=null, refAbstract=null), Reference(id=1327671331103027211, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=TUCCI F, GALIMBERTI S, NALDINI L, et al.A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders [J].Nat Commun, 2022, 13(1): 1315., articleTitle=null, refAbstract=null), Reference(id=1327671331170136076, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=BULCHA J T, WANG Y, MA H, et al.Viral vector platforms within the gene therapy landscape [J].Signal Transduct Target Ther, 2021, 6(1): 53., articleTitle=null, refAbstract=null), Reference(id=1327671331233050637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=CRENSHAW B J, JONES L B, BELL C R, et al.Perspective on adenoviruses: epidemiology, pathogenicity, and gene therapy [J].Biomedicines, 2019, 7(3): 61., articleTitle=null, refAbstract=null), Reference(id=1327671331300159502, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=SINGH S, KUMAR R, AGRAWAL B.Adenoviral vector-based vaccines and gene therapies: current status and future prospects [M]// DESHEVA Y.Adenoviruses.London: IntechOpen, 2019: 53-91., articleTitle=null, refAbstract=null), Reference(id=1327671331371462671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=MENNECHET F J D, PARIS O, OUOBA A R, et al.A review of 65 years of human adenovirus seroprevalence[J].Expert Rev Vaccines, 2019, 18(6): 597-613., articleTitle=null, refAbstract=null), Reference(id=1327671331430182928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LI C W, SAMULSKI R J.Engineering adeno-associated virus vectors for gene therapy [J].Nat Rev Genet, 2020,21(4): 255-272., articleTitle=null, refAbstract=null), Reference(id=1327671331535040529, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=DUAN L, XU L M, XU X, et al.Exosome-mediated delivery of gene vectors for gene therapy [J].Nanoscale,2021, 13(3): 1387-1397., articleTitle=null, refAbstract=null), Reference(id=1327671331618926610, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=KEISER M S, RANUM P T, YRIGOLLEN C M, et al.Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain [J].Nat Med, 2021, 27(11):1982-1989., articleTitle=null, refAbstract=null), Reference(id=1327671331694424083, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Cellular, tissue, and gene therapies advisory committee september 2, 2021 meeting presentation- toxicity risks of adeno-associated virus(AAV) vectors for gene therapy(GT) [EB/OL].[2022-03-04].https://www.fda.gov/media/151969/download., articleTitle=null, refAbstract=null), Reference(id=1327671331761532948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=HINDERER C, KATZ N, BUZA E L, et al.Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN [J].Hum Gene Ther, 2018,29(3): 285-298., articleTitle=null, refAbstract=null), Reference(id=1327671331828641813, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=YONEZAWA S, KOIDE H, ASAI T.Recent advances in siRNA delivery mediated by lipid-based nanoparticles [J].Adv Drug Deliv Rev, 2020, 154-155: 64-78., articleTitle=null, refAbstract=null), Reference(id=1327671331904139286, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=CHARBE N B, AMNERKAR N D, RAMESH B, et al.Small interfering RNA for cancer treatment: overcoming hurdles in delivery [J].Acta Pharm Sin B, 2020, 10(11):2075-2109., articleTitle=null, refAbstract=null), Reference(id=1327671331967053847, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=VERBEKE R, LENTACKER I, DE SMEDT S C, et al.The dawn of mRNA vaccines: the COVID-19 case [J].J Control Release, 2021, 333: 511-520., articleTitle=null, refAbstract=null), Reference(id=1327671332050939928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=HALAMODA-KENZAOUI B, BREMER-HOFFMANN S.Main trends of immune effects triggered by nanomedicines in preclinical studies [J].Int J Nanomedicine, 2018, 13: 5419-5431., articleTitle=null, refAbstract=null), Reference(id=1327671332134826009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=SEDIC M, SENN J J, LYNN A, et al.Safety evaluation of lipid nanoparticle-formulated modified mRNA in the sprague-dawley rat and cynomolgus monkey [J].Vet Pathol, 2018,55(2): 341-354., articleTitle=null, refAbstract=null), Reference(id=1327671332206129178, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=AKINC A, QUERBES W, DE S, et al.Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms [J].Mol Ther, 2010, 18(7): 1357-1364., articleTitle=null, refAbstract=null), Reference(id=1327671332294209563, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=BURNETT J C, ROSSI J J.RNA-based therapeutics: current progress and future prospects [J].Chem Biol, 2012,19(1): 60-71., articleTitle=null, refAbstract=null), Reference(id=1327671332361318428, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=THI T T H, SUYS E J A, LEE J S, et al.Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines [J].Vaccines(Basel),2021, 9(4): 359., articleTitle=null, refAbstract=null), Reference(id=1327671332428427293, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=VLATKOVIC I.Non-immunotherapy application of LNP-mRNA: maximizing efficacy and safety [J].Biomedicines,2021, 9(5): 530., articleTitle=null, refAbstract=null), Reference(id=1327671332491341854, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=XU L, ZHANG H, WU Y.Dendrimer advances for the central nervous system delivery of therapeutics [J].ACS Chem Neurosci, 2014, 5(1): 2-13., articleTitle=null, refAbstract=null), Reference(id=1327671332554256415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=KHAN O F, ZAIA E W, YIN H, et al.Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivo [J].Angew Chem Int Ed Engl, 2014, 53(52): 14397-14401., articleTitle=null, refAbstract=null), Reference(id=1327671332612976672, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=YAN Y, LIU X Y, LU A, et al.Non-viral vectors for RNA delivery [J].J Control Release, 2022, 342: 241-279., articleTitle=null, refAbstract=null), Reference(id=1327671332688474145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=LIANG X, LIU L, WEI Y Q, et al.Clinical evaluations of toxicity and efficacy of nanoparticle-mediated gene therapy[J].Hum Gene Ther, 2018, 29(11): 1227-1234., articleTitle=null, refAbstract=null), Reference(id=1327671332763971618, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=KOKKINOS J, IGNACIO R M C, SHARBEEN G, et al.Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs [J].Biomaterials, 2020, 240:119742., articleTitle=null, refAbstract=null), Reference(id=1327671332843663395, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=ELSAESSER A, HOWARD C V.Toxicology of nanoparticles [J].Adv Drug Deliv Rev, 2012, 64(2): 129-137., articleTitle=null, refAbstract=null), Reference(id=1327671332935938084, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG H, FENG W, CHEN Y, et al.Inorganic nanoparticles in clinical trials and translations [J].Nano Today, 2020, 35: 100972., articleTitle=null, refAbstract=null), Reference(id=1327671333011435557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=PENG F, SETYAWATI M I, TEE J K, et al.Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness [J].Nat Nanotechnol, 2019, 14(3): 279-286., articleTitle=null, refAbstract=null), Reference(id=1327671334684962854, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=DEBACKER A J, VOUTILA J, CATLEY M, et al.Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug [J].Mol Ther, 2020, 28(8):1759-1771., articleTitle=null, refAbstract=null), Reference(id=1327671334781431847, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=MURPHY D E, DE JONG O G, BROUWER M, et al.Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking [J].Exp Mol Med,2019, 51(3): 1-12., articleTitle=null, refAbstract=null), Reference(id=1327671334877900840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=HERRMANN I K, WOOD M J A, FUHRMANN G.Extracellular vesicles as a next-generation drug delivery platform [J].Nat Nanotechnol, 2021, 16(7): 748-759., articleTitle=null, refAbstract=null), Reference(id=1327671335062450217, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=ELSHARKASY O M, NORDIN J Z, HAGEY D W, et al.Extracellular vesicles as drug delivery systems: why and how? [J].Adv Drug Deliv Rev, 2020, 159: 332-343., articleTitle=null, refAbstract=null), Reference(id=1327671335142141994, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=LAMICHHANE T N, JEYARAM A, PATEL D B, et al.Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication [J].Cell Mol Bioeng,2016, 9(3): 315-324., articleTitle=null, refAbstract=null), Reference(id=1327671335230222379, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=BAI J, DUAN J L, LIU R, et al.Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells [J].Asian J Pharm Sci, 2020,15(4): 461-471., articleTitle=null, refAbstract=null), Reference(id=1327671335318302764, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=LIMONI S K, MOGHADAM M F, MOAZZENI S M, et al.Engineered exosomes for targeted transfer of siRNA to HER2 positive breast cancer cells [J].Appl Biochem Biotechnol,2019, 187(1): 352-364., articleTitle=null, refAbstract=null), Reference(id=1327671335410577453, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO L W, GU C Y, GAN Y, et al.Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis [J].J Control Release, 2020, 318: 1-15., articleTitle=null, refAbstract=null), Reference(id=1327671335490269230, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=LAMICHHANE T N, RAIKER R S, JAY S M.Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery [J].Mol Pharm, 2015, 12(10): 3650-3657., articleTitle=null, refAbstract=null), Reference(id=1327671335557378095, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=MUNAGALA R, AQIL F, JEYABALAN J, et al.Exosome-mediated delivery of RNA and DNA for gene therapy [J].Cancer Lett, 2021, 505: 58-72., articleTitle=null, refAbstract=null), Reference(id=1327671335628681264, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO S W, PERETS N, BETZER O, et al.Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury [J].ACS Nano, 2019, 13(9):10015-10028., articleTitle=null, refAbstract=null), Reference(id=1327671335746121777, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO Y T, WAN Z, ZHAO P, et al.Ultrasound triggered topical delivery of Bmp7 mRNA for white fat browning induction via engineered smart exosomes [J].J Nanobiotechnology, 2021, 19(1): 1-13., articleTitle=null, refAbstract=null), Reference(id=1327671335821619250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=BRYNIARSKI K, PTAK W, JAYAKUMAR A, et al.Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity [J].J Allergy Clin Immunol,2013, 132(1): 170-181., articleTitle=null, refAbstract=null), Reference(id=1327671335880339507, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=LIANG G F, KAN S, ZHU Y L, et al.Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [J].Int J Nanomedicine, 2018, 13: 585-599., articleTitle=null, refAbstract=null), Reference(id=1327671335947448372, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=TSAI S J, ATAI N A, CACCIOTTOLO M, et al.Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity [J].J Biol Chem, 2021,297(5): 101266., articleTitle=null, refAbstract=null), Reference(id=1327671336006168629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=BU T, LI Z L, HOU Y, et al.Exosome-mediated delivery of inflammation-responsive Il-10 mRNA for controlled atherosclerosis treatment [J].Theranostics, 2021, 11(20):9988-10000., articleTitle=null, refAbstract=null), Reference(id=1327671336064888886, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=LIANG G F, ZHU Y L, ALI D J, et al.Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer[J].J Nanobiotechnology, 2020, 18(1): 1-15., articleTitle=null, refAbstract=null), Reference(id=1327671336127803447, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=LIANG Y J, XU X, LI X F, et al.Chondrocyte-targeted microRNA delivery by engineered exosomes toward a cell-free osteoarthritis therapy [J].ACS Appl Mater Interfaces,2020, 12(33): 36938-36947., articleTitle=null, refAbstract=null), Reference(id=1327671336203300920, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=PI F M, BINZEL D W, LEE T J, et al.Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression [J].Nat Nanotechnol, 2018, 13(1): 82-89., articleTitle=null, refAbstract=null), Reference(id=1327671336278798393, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Y Y, CHEN X J, TIAN B Q, et al.Nucleolin-targeted extracellular vesicles as a versatile platform for biologics delivery to breast cancer [J].Theranostics, 2017,7(5): 1360-1372., articleTitle=null, refAbstract=null), Reference(id=1327671336358490170, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=MCANDREWS K M, XIAO F, CHRONOPOULOS A, et al.Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer [J].Life Sci Alliance, 2021, 4(9): e202000875., articleTitle=null, refAbstract=null), Reference(id=1327671336446570555, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=BABAN C K, CRONIN M, O’HANLON D, et al.Bacteria as vectors for gene therapy of cancer [J].Bioeng Bugs,2010, 1(6): 385-394., articleTitle=null, refAbstract=null), Reference(id=1327671336513679420, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN W F, WANG Y, QIN M, et al.Bacteria-driven hypoxia targeting for combined biotherapy and photothermal therapy [J].ACS Nano, 2018, 12(6): 5995-6005., articleTitle=null, refAbstract=null), Reference(id=1327671336576593981, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=SALEM-BEKHIT M M, YOUSSOF A M E, ALANAZI F K, et al.Bacteria from infectious particles to cell based anticancer targeted drug delivery systems [J].Pharmaceutics, 2021, 13(12): 1984., articleTitle=null, refAbstract=null), Reference(id=1327671336668868670, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=YU A M, BATRA N, TU M J, et al.Novel approaches for efficient in vivo fermentation production of noncoding RNAs[J].Appl Microbiol Biotechnol, 2020, 104(5): 1927-1937., articleTitle=null, refAbstract=null), Reference(id=1327671336744366143, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=OREFICE N S, SOUCHET B, BRAUDEAU J, et al.Real-time monitoring of exosome enveloped-AAV spreading by endomicroscopy approach: a new tool for gene delivery in the brain [J].Mol Ther Methods Clin Dev, 2019, 14: 237-251., articleTitle=null, refAbstract=null)], funds=[Fund(id=1327671330901700617, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, awardId=BM2021002, language=CN, fundingSource=江苏省创新能力建设计划科技公共服务平台项目(BM2021002), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1327671327063913433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=1., ext=[AuthorCompanyExt(id=1327671327072302042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671327080690651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203)]), AuthorCompany(id=1327671327143605212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=2., ext=[AuthorCompanyExt(id=1327671327147799517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327143605212, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.InnoStar Biotech Nantong Co., Ltd., Nantong 226133), AuthorCompanyExt(id=1327671327156188126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327143605212, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.益诺思生物技术南通有限公司,江苏 南通 226133)]), AuthorCompany(id=1327671327214908383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=3., ext=[AuthorCompanyExt(id=1327671327223296992, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327214908383, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.College of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230012), AuthorCompanyExt(id=1327671327231685601, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327214908383, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.安徽中医药大学药学院,安徽 合肥 230012)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.12.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.12.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.12.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.12.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1670601600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
基因治疗递送载体应用现状及安全性研究进展
李嫚琪 1 , 魏丽萍 1, 2 , 陶巧玉 2, 3 , 何伟伟 1 , 常艳 1, *
中国医药工业杂志 | 专论 2022,53(12): 1671-1682
收起
收藏切换
中国医药工业杂志 |专论 2022 , 53 (12) : 1671 -1682
基因治疗递送载体应用现状及安全性研究进展
全屏
[Author(id=1327671327286211555, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671327365903333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327286211555, language=EN, stringName=Manqi LI, firstName=Manqi, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671327433012198, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327286211555, language=CN, stringName=李嫚琪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203, bio={"content":"

李嫚琪(1997—),女,硕士,从事药物毒理学研究。

"}, bioImg=null, bioContent=

李嫚琪(1997—),女,硕士,从事药物毒理学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671327063913433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=1., ext=[AuthorCompanyExt(id=1327671327072302042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671327080690651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1327671327491732456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671327567229931, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327491732456, language=EN, stringName=Liping WEI, firstName=Liping, middleName=null, lastName=WEI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203
2.InnoStar Biotech Nantong Co., Ltd., Nantong 226133, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671327642727404, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327491732456, language=CN, stringName=魏丽萍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203
2.益诺思生物技术南通有限公司,江苏 南通 226133, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671327063913433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=1., ext=[AuthorCompanyExt(id=1327671327072302042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671327080690651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203)]), AuthorCompany(id=1327671327143605212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=2., ext=[AuthorCompanyExt(id=1327671327147799517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327143605212, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.InnoStar Biotech Nantong Co., Ltd., Nantong 226133), AuthorCompanyExt(id=1327671327156188126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327143605212, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.益诺思生物技术南通有限公司,江苏 南通 226133)])]), Author(id=1327671327705641966, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671327793722353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327705641966, language=EN, stringName=Qiaoyu TAO, firstName=Qiaoyu, middleName=null, lastName=TAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2.InnoStar Biotech Nantong Co., Ltd., Nantong 226133
3.College of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671327869219826, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327705641966, language=CN, stringName=陶巧玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2.益诺思生物技术南通有限公司,江苏 南通 226133
3.安徽中医药大学药学院,安徽 合肥 230012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671327143605212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=2., ext=[AuthorCompanyExt(id=1327671327147799517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327143605212, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.InnoStar Biotech Nantong Co., Ltd., Nantong 226133), AuthorCompanyExt(id=1327671327156188126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327143605212, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.益诺思生物技术南通有限公司,江苏 南通 226133)]), AuthorCompany(id=1327671327214908383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=3., ext=[AuthorCompanyExt(id=1327671327223296992, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327214908383, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.College of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230012), AuthorCompanyExt(id=1327671327231685601, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327214908383, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.安徽中医药大学药学院,安徽 合肥 230012)])]), Author(id=1327671327965688820, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671328045380598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327965688820, language=EN, stringName=Weiwei HE, firstName=Weiwei, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671328120878071, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671327965688820, language=CN, stringName=何伟伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671327063913433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=1., ext=[AuthorCompanyExt(id=1327671327072302042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671327080690651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1327671328179598329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=ychang@innostar.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327671328250901499, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671328179598329, language=EN, stringName=Yan CHANG, firstName=Yan, middleName=null, lastName=CHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671328305427452, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, authorId=1327671328179598329, language=CN, stringName=常艳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671327063913433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, xref=1., ext=[AuthorCompanyExt(id=1327671327072302042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671327080690651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671167764247197, companyId=1327671327063913433, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203)])])]
李嫚琪1, 魏丽萍1, 2, 陶巧玉2, 3, 何伟伟1, 常艳1, *
作者信息
  • 1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203
  • 2.益诺思生物技术南通有限公司,江苏 南通 226133
  • 3.安徽中医药大学药学院,安徽 合肥 230012
通讯作者:
常艳(1974—),女,研究员,博士生导师,从事药物毒理学研究。E-mail:
作者简介:

常艳,女,博士,中国毒理学会认证毒理学家(DCST),荣获“上海市科学技术带头人”“上海领军人才”“上海市三八红旗手”等称号以及“上海市五一劳动奖章”,现任上海益诺思生物技术股份有限公司总经理。中国医药工业研究总院研究员,博士生导师;复旦大学博士生导师;长三角药学高等工程学院硕士生导师;上海工程技术大学硕士生导师。兼任国家食品药品监督管理局药品审评及GLP检查专家、OECD Pig-a指导原则专家组成员、NMPA CDE ICH S5和S12专家组成员、NMPA CDE遗传毒性指导原则专家组成员。长期从事新药安全性评价研究,承担或参与国家级及其他政府科技项目20余项,累计发表文章70余篇,累计申请国内专利14项,其中发明专利3项,已授权专利10项。共培养博士研究生1名(以毕业计),另有7名在读;共培养硕士研究生15人(以毕业计),另有在读6人。

李嫚琪(1997—),女,硕士,从事药物毒理学研究。

Application Status and Research Progress on Safety of Gene Therapy Delivery Vectors
Manqi LI1, Liping WEI1, 2, Qiaoyu TAO2, 3, Weiwei HE1, Yan CHANG1, *
Affiliations
  • 1.Shanghai InnoStar Biotech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2.InnoStar Biotech Nantong Co., Ltd., Nantong 226133
  • 3.College of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230012
出版时间: 2022-12-10 doi: 10.16522/j.cnki.cjph.2022.12.001
文章导航
收藏切换

通过载体将基因药物高效递送至靶组织或靶细胞是基因治疗的关键步骤。选择合适、安全、有效的递送系统是基因疗法中亟待解决的任务。目前采用的基因药物递送载体可分为病毒载体和非病毒载体。该综述介绍了基因治疗中常见的病毒载体、合成非病毒载体和生物非病毒载体的应用现状和相关安全性问题,比较了不同载体的优缺点,并总结了基因递送载体非临床安全性评价考虑要点,以期为基因治疗领域的载体的选择、使用及安全性评价提供参考。

基因递送载体  /  病毒载体  /  非病毒载体  /  合成载体  /  生物载体  /  安全性

The efficient delivery of genes to target tissues or target cells by vectors is a critical step in gene therapy. Selecting a suitable, safe, and effective gene delivery vector is an urgent task in gene therapy. Gene therapy delivery vectors can be divided into two categories, viral vectors and nonviral vectors. In this review, the current application status and safety of viral vectors, synthetic nonviral vectors, and biological nonviral vectors are summarized, and the advantages and disadvantages of various delivery vectors are compared. Furthermore, the key points for evaluating the nonclinical safety of gene delivery vectors are summarized to provide references for the selection, application, and safety evaluation of vectors in the field of gene therapy.

gene delivery vector  /  viral vector  /  nonviral vector  /  synthetic vector  /  biological vector  /  safety
李嫚琪, 魏丽萍, 陶巧玉, 何伟伟, 常艳. 基因治疗递送载体应用现状及安全性研究进展. 中国医药工业杂志, 2022 , 53 (12) : 1671 -1682 . DOI: 10.16522/j.cnki.cjph.2022.12.001
Manqi LI, Liping WEI, Qiaoyu TAO, Weiwei HE, Yan CHANG. Application Status and Research Progress on Safety of Gene Therapy Delivery Vectors[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (12) : 1671 -1682 . DOI: 10.16522/j.cnki.cjph.2022.12.001
  • 江苏省创新能力建设计划科技公共服务平台项目(BM2021002)
参考文献 引证文献
排序方式:
[1]
ALHAKAMY N A, CURIEL D T, BERKLAND C J.The era of gene therapy: from preclinical development to clinical application [J].Drug Discov Today, 2021, 26(7): 1602-1619.
[2]
TUCCI F, GALIMBERTI S, NALDINI L, et al.A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders [J].Nat Commun, 2022, 13(1): 1315.
[3]
BULCHA J T, WANG Y, MA H, et al.Viral vector platforms within the gene therapy landscape [J].Signal Transduct Target Ther, 2021, 6(1): 53.
[4]
CRENSHAW B J, JONES L B, BELL C R, et al.Perspective on adenoviruses: epidemiology, pathogenicity, and gene therapy [J].Biomedicines, 2019, 7(3): 61.
[5]
SINGH S, KUMAR R, AGRAWAL B.Adenoviral vector-based vaccines and gene therapies: current status and future prospects [M]// DESHEVA Y.Adenoviruses.London: IntechOpen, 2019: 53-91.
[6]
MENNECHET F J D, PARIS O, OUOBA A R, et al.A review of 65 years of human adenovirus seroprevalence[J].Expert Rev Vaccines, 2019, 18(6): 597-613.
[7]
LI C W, SAMULSKI R J.Engineering adeno-associated virus vectors for gene therapy [J].Nat Rev Genet, 2020,21(4): 255-272.
[8]
DUAN L, XU L M, XU X, et al.Exosome-mediated delivery of gene vectors for gene therapy [J].Nanoscale,2021, 13(3): 1387-1397.
[9]
KEISER M S, RANUM P T, YRIGOLLEN C M, et al.Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain [J].Nat Med, 2021, 27(11):1982-1989.
[10]
FDA.Cellular, tissue, and gene therapies advisory committee september 2, 2021 meeting presentation- toxicity risks of adeno-associated virus(AAV) vectors for gene therapy(GT) [EB/OL].[2022-03-04].https://www.fda.gov/media/151969/download.
[11]
HINDERER C, KATZ N, BUZA E L, et al.Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN [J].Hum Gene Ther, 2018,29(3): 285-298.
[12]
YONEZAWA S, KOIDE H, ASAI T.Recent advances in siRNA delivery mediated by lipid-based nanoparticles [J].Adv Drug Deliv Rev, 2020, 154-155: 64-78.
[13]
CHARBE N B, AMNERKAR N D, RAMESH B, et al.Small interfering RNA for cancer treatment: overcoming hurdles in delivery [J].Acta Pharm Sin B, 2020, 10(11):2075-2109.
[14]
VERBEKE R, LENTACKER I, DE SMEDT S C, et al.The dawn of mRNA vaccines: the COVID-19 case [J].J Control Release, 2021, 333: 511-520.
[15]
HALAMODA-KENZAOUI B, BREMER-HOFFMANN S.Main trends of immune effects triggered by nanomedicines in preclinical studies [J].Int J Nanomedicine, 2018, 13: 5419-5431.
[16]
SEDIC M, SENN J J, LYNN A, et al.Safety evaluation of lipid nanoparticle-formulated modified mRNA in the sprague-dawley rat and cynomolgus monkey [J].Vet Pathol, 2018,55(2): 341-354.
[17]
AKINC A, QUERBES W, DE S, et al.Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms [J].Mol Ther, 2010, 18(7): 1357-1364.
[18]
BURNETT J C, ROSSI J J.RNA-based therapeutics: current progress and future prospects [J].Chem Biol, 2012,19(1): 60-71.
[19]
THI T T H, SUYS E J A, LEE J S, et al.Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines [J].Vaccines(Basel),2021, 9(4): 359.
[20]
VLATKOVIC I.Non-immunotherapy application of LNP-mRNA: maximizing efficacy and safety [J].Biomedicines,2021, 9(5): 530.
[21]
XU L, ZHANG H, WU Y.Dendrimer advances for the central nervous system delivery of therapeutics [J].ACS Chem Neurosci, 2014, 5(1): 2-13.
[22]
KHAN O F, ZAIA E W, YIN H, et al.Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivo [J].Angew Chem Int Ed Engl, 2014, 53(52): 14397-14401.
[23]
YAN Y, LIU X Y, LU A, et al.Non-viral vectors for RNA delivery [J].J Control Release, 2022, 342: 241-279.
[24]
LIANG X, LIU L, WEI Y Q, et al.Clinical evaluations of toxicity and efficacy of nanoparticle-mediated gene therapy[J].Hum Gene Ther, 2018, 29(11): 1227-1234.
[25]
KOKKINOS J, IGNACIO R M C, SHARBEEN G, et al.Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs [J].Biomaterials, 2020, 240:119742.
[26]
ELSAESSER A, HOWARD C V.Toxicology of nanoparticles [J].Adv Drug Deliv Rev, 2012, 64(2): 129-137.
[27]
HUANG H, FENG W, CHEN Y, et al.Inorganic nanoparticles in clinical trials and translations [J].Nano Today, 2020, 35: 100972.
[28]
PENG F, SETYAWATI M I, TEE J K, et al.Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness [J].Nat Nanotechnol, 2019, 14(3): 279-286.
[29]
DEBACKER A J, VOUTILA J, CATLEY M, et al.Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug [J].Mol Ther, 2020, 28(8):1759-1771.
[30]
MURPHY D E, DE JONG O G, BROUWER M, et al.Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking [J].Exp Mol Med,2019, 51(3): 1-12.
[31]
HERRMANN I K, WOOD M J A, FUHRMANN G.Extracellular vesicles as a next-generation drug delivery platform [J].Nat Nanotechnol, 2021, 16(7): 748-759.
[32]
ELSHARKASY O M, NORDIN J Z, HAGEY D W, et al.Extracellular vesicles as drug delivery systems: why and how? [J].Adv Drug Deliv Rev, 2020, 159: 332-343.
[33]
LAMICHHANE T N, JEYARAM A, PATEL D B, et al.Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication [J].Cell Mol Bioeng,2016, 9(3): 315-324.
[34]
BAI J, DUAN J L, LIU R, et al.Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells [J].Asian J Pharm Sci, 2020,15(4): 461-471.
[35]
LIMONI S K, MOGHADAM M F, MOAZZENI S M, et al.Engineered exosomes for targeted transfer of siRNA to HER2 positive breast cancer cells [J].Appl Biochem Biotechnol,2019, 187(1): 352-364.
[36]
ZHAO L W, GU C Y, GAN Y, et al.Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis [J].J Control Release, 2020, 318: 1-15.
[37]
LAMICHHANE T N, RAIKER R S, JAY S M.Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery [J].Mol Pharm, 2015, 12(10): 3650-3657.
[38]
MUNAGALA R, AQIL F, JEYABALAN J, et al.Exosome-mediated delivery of RNA and DNA for gene therapy [J].Cancer Lett, 2021, 505: 58-72.
[39]
GUO S W, PERETS N, BETZER O, et al.Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury [J].ACS Nano, 2019, 13(9):10015-10028.
[40]
GUO Y T, WAN Z, ZHAO P, et al.Ultrasound triggered topical delivery of Bmp7 mRNA for white fat browning induction via engineered smart exosomes [J].J Nanobiotechnology, 2021, 19(1): 1-13.
[41]
BRYNIARSKI K, PTAK W, JAYAKUMAR A, et al.Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity [J].J Allergy Clin Immunol,2013, 132(1): 170-181.
[42]
LIANG G F, KAN S, ZHU Y L, et al.Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [J].Int J Nanomedicine, 2018, 13: 585-599.
[43]
TSAI S J, ATAI N A, CACCIOTTOLO M, et al.Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity [J].J Biol Chem, 2021,297(5): 101266.
[44]
BU T, LI Z L, HOU Y, et al.Exosome-mediated delivery of inflammation-responsive Il-10 mRNA for controlled atherosclerosis treatment [J].Theranostics, 2021, 11(20):9988-10000.
[45]
LIANG G F, ZHU Y L, ALI D J, et al.Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer[J].J Nanobiotechnology, 2020, 18(1): 1-15.
[46]
LIANG Y J, XU X, LI X F, et al.Chondrocyte-targeted microRNA delivery by engineered exosomes toward a cell-free osteoarthritis therapy [J].ACS Appl Mater Interfaces,2020, 12(33): 36938-36947.
[47]
PI F M, BINZEL D W, LEE T J, et al.Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression [J].Nat Nanotechnol, 2018, 13(1): 82-89.
[48]
WANG Y Y, CHEN X J, TIAN B Q, et al.Nucleolin-targeted extracellular vesicles as a versatile platform for biologics delivery to breast cancer [J].Theranostics, 2017,7(5): 1360-1372.
[49]
MCANDREWS K M, XIAO F, CHRONOPOULOS A, et al.Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer [J].Life Sci Alliance, 2021, 4(9): e202000875.
[50]
BABAN C K, CRONIN M, O’HANLON D, et al.Bacteria as vectors for gene therapy of cancer [J].Bioeng Bugs,2010, 1(6): 385-394.
[51]
CHEN W F, WANG Y, QIN M, et al.Bacteria-driven hypoxia targeting for combined biotherapy and photothermal therapy [J].ACS Nano, 2018, 12(6): 5995-6005.
[52]
SALEM-BEKHIT M M, YOUSSOF A M E, ALANAZI F K, et al.Bacteria from infectious particles to cell based anticancer targeted drug delivery systems [J].Pharmaceutics, 2021, 13(12): 1984.
[53]
YU A M, BATRA N, TU M J, et al.Novel approaches for efficient in vivo fermentation production of noncoding RNAs[J].Appl Microbiol Biotechnol, 2020, 104(5): 1927-1937.
[54]
OREFICE N S, SOUCHET B, BRAUDEAU J, et al.Real-time monitoring of exosome enveloped-AAV spreading by endomicroscopy approach: a new tool for gene delivery in the brain [J].Mol Ther Methods Clin Dev, 2019, 14: 237-251.
2022年第53卷第12期
75
13
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.12.001
  • 接收时间:2022-08-13
  • 首发时间:2026-11-12
  • 出版时间:2022-12-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-08-13
基金
江苏省创新能力建设计划科技公共服务平台项目(BM2021002)
作者信息
    1.中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203
    2.益诺思生物技术南通有限公司,江苏 南通 226133
    3.安徽中医药大学药学院,安徽 合肥 230012

通讯作者:

常艳(1974—),女,研究员,博士生导师,从事药物毒理学研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.12.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏